fig2

The European joint programme on rare diseases: building the rare diseases research ecosystem

Figure 2. Distribution of 215 projects funded by EJP RD and E-Rare from 2007 to 2023 (including 207 JTCs, 3 RDRC and 5 Demonstration/Innovation funded projects) throughout the research pipeline. All research projects have been analysed to classify their work into categories[19] and grouped into 6 non-exclusive categories: molecular and pathophysiological studies; diagnostic studies; preclinical and validation studies; clinical studies; epidemiology and natural history studies; social sciences and humanities studies. Many of the projects could be assigned to more than one category, which is reflected in the numbers of project distribution. Epidemiology and natural history studies and social sciences and humanities studies have been found to be associated with different steps of the research pipeline in funded projects, and thus, they have been identified as overarching research topics. Numbers of projects in those 2 arrow groups projects focusing only on this topic or in combination with any of the other 4 topics (molecular and pathophysiological studies; diagnostic studies; preclinical and validation studies; clinical studies). MP: Molecular and pathophysiological studies.

Rare Disease and Orphan Drugs Journal
ISSN 2771-2893 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/